Meeting
2022 ASCO Annual Meeting
Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and to better predict intracranial tumor response in patients with non–small cell lung cancer with brain metastases: A prospective cohort study.
Authors
Meichen Li
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
Meichen Li , Xue Hou , Jing Chen , Baishen Zhang , Juan Yu , Na Wang , Delan Li , Yang Shao , Dongqin Zhu , Chuqiao Liang , Qiuxiang Ou , Yutong Ma , Likun Chen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Brain Metastases
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 2023)
DOI
10.1200/JCO.2022.40.16_suppl.2023
Abstract #
2023
Poster Bd #
361
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Breakthrough
CRISPincette, and detection of low frequency cancer mutations in ctDNA.
First Author: Jin-Soo Kim
Poster
2023 ASCO Annual Meeting
Cerebrospinal fluid immunological cytokines to predict intracranial tumor response to immunotherapy in non-small cell lung cancer patients with brain metastases: GASTO 1060.
First Author: Likun Chen
Poster
2019 ASCO Annual Meeting
Cost-minimization analysis of using tumor cell-free DNA as monitoring tool in cancer immunotherapy.
First Author: Alexander Kuhlmann
Poster
2017 ASCO Annual Meeting
Detection of tumor-derived DNA mutations in cerebrospinal fluid of patients with primary or metastatic brain tumors.
First Author: Jianfei Wang